- Home
- VSNT vs TFX Comparison
VSNT vs TFX Comparison
Compare VSNT & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VSNT | TFX |
|---|---|---|
| Founded | 2025 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.8B |
| IPO Year | 2025 | 1994 |
Fundamental Metrics
Financial Performance| Metric | VSNT | TFX |
|---|---|---|
| Price | $39.20 | $133.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $43.67 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.8M | 525.7K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.79% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.49 | 2.08 |
| Revenue | ★ $6,688,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | ★ $11.36 | $65.95 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.17 | $100.18 |
| 52 Week High | $45.58 | $145.00 |
Technical Indicators
Market Signals| Indicator | VSNT | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 48.34 |
| Support Level | $34.95 | $129.02 |
| Resistance Level | $42.17 | $137.40 |
| Average True Range (ATR) | 1.32 | 4.95 |
| MACD | 0.35 | -0.27 |
| Stochastic Oscillator | 55.48 | 24.43 |
Price Performance
Historical ComparisonAbout VSNT Versant Media Group Inc. Class A Common Stock
Versant Media Group Inc is an independent media company comprised of NBCUniversal's cable television networks, including USA Network, CNBC, MSNBC, Oxygen, SYFY, and Golf Channel, along with complementary digital assets Fandango, Rotten Tomatoes, GolfNow, GolfPass, and SportsEngine.
About TFX Teleflex Incorporated
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.